Figure 3.

Recurrence-free and breast cancer-specific survival according to combinations of oestrogen receptor (ER) status and HMG-CoA reductase expression. Kaplan-Meier estimates of (a) recurrence-free and (b) breast cancer-specific survival according to combinations of ER-status (negative/positive) and HMG-CoA reductase expression (negative [0]/positive [1 to 3]).